3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
6
Polycystic Ovary Syndrome
4
Obesity
4
Neoplasms
3
Motor Activity
3
Ovarian Diseases
2
Ovarian Cysts
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Cardiovascular Diseases
2
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Overweight
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Monoclonal Gammopathy of Undetermined Significance
1
Metabolic Syndrome
1
Intermittent Fasting
1
Inflammation
1
Growth Hormone-Secreting Pituitary Adenoma
1
Fibrosis
1
Feeding Behavior
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Carcinoma, Hepatocellular
1
Angina, Unstable
1
Interventions
Peripheral Blood Stem Cell Transplantation
4
Cyclophosphamide
4
Epoetin Alfa
3
Darbepoetin alfa
3
Curcumin
3
liposomal amphotericin B
2
fludarabine phosphate
2
Morphine
2
Methylprednisolone
2
Interferon-alpha
2
Filgrastim
2
Cyclosporine
2
Caspofungin
2
Carboplatin
2
Bortezomib
2
Antilymphocyte Serum
2
tanespimycin
1
siltuximab
1
sargramostim
1
pyroxamide
1
piperine
1
isatuximab
1
ibrutinib
1
ferrous sulfate
1
ferric gluconate
1
alethine
1
aldesleukin
1
Whole-Body Irradiation
1
Topotecan
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Monoclonal Gammopathy of Undetermined Significance
×
Diet, Mediterranean
×
Clear all
NCT07446777
2026-05-01
FAST-M
University of Miami
Phase NA
Recruiting
120 enrolled